Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
Study NCT ID:
NCT00786851
Status:
COMPLETED
Last Update Posted:
2016-08-17
First Post:
2008-11-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Sponsor:
Fondazione Italiana Linfomi - ETS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIL LEN-DEX MCL 07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |